Abstract | OBJECTIVE: METHODS:
VEGF-D was measured in fasting blood samples of 4689 subjects (40% men) without a history of AF from the Malmö Diet and Cancer Study, a prospective, population-based study in Sweden. Median age was 58 years (range 46-68). Cox regression analyses, adjusted for multiple risk factors, was used to assess AF and ischaemic stroke risk in relation to VEGF-D levels. RESULTS: During a median follow-up time of 20.6 years, there were 637 cases of incident AF and 322 cases of first ischaemic stroke. After adjustment, VEGF-D was significantly associated with AF (HR 1.13(95% CI 1.04 to 1.23) per 1 SD increase) and ischaemic stroke (HR 1.14(95% CI 1.02 to 1.28) per 1 SD). The association with ischaemic stroke was explained by an increased incidence of AF-related stroke. HRs per 1 SD were 1.34 (95% CI 1.04 to 1.71) for AF-related ischaemic stroke and 1.04 (95% CI 0.90 to 1.19) for ischaemic stroke without AF. CONCLUSIONS:
|
Authors | John Berntsson, J Gustav Smith, Linda S B Johnson, Martin Söderholm, Yan Borné, Olle Melander, Marju Orho-Melander, Jan Nilsson, Gunnar Engström |
Journal | Heart (British Cardiac Society)
(Heart)
Vol. 105
Issue 7
Pg. 553-558
(04 2019)
ISSN: 1468-201X [Electronic] England |
PMID | 30327392
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ. |
Chemical References |
- Vascular Endothelial Growth Factor D
|
Topics |
- Atrial Fibrillation
(blood, complications, epidemiology)
- Correlation of Data
- Female
- Follow-Up Studies
- Humans
- Incidence
- Male
- Risk Assessment
- Risk Factors
- Stroke
(blood, epidemiology, etiology)
- Sweden
(epidemiology)
- Vascular Endothelial Growth Factor D
(blood)
|